Anti-cancer compounds targeting Ral GTPases and methods of using the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11472812
APP PUB NO 20200255442A1
SERIAL NO

16863867

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of inhibiting the growth or metastasis of a cancer in a subject by inhibiting a Ral GTPase in the subject, and small molecule inhibitors of Ral GTPases useful in the methods of the invention. Pharmaceutical compositions containing the compounds of the invention, and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Reigan, Phillip Denver, US 7 18
Ross, David Niwot, US 154 5840
Theodorescu, Dan Englewood, US 16 43
Wempe, Michael Fitzpatrick Aurora, US 16 64
Yan, Chao Denver, US 123 713

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00